---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-027585"
form_type: "8-K"
ticker: "XTNT"
cik: "0001453593"
company_name: "Xtant Medical Holdings, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T17:09:31.610052+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Xtant Medical completes acquisition of Surgalign's hardware and biologics business for $5 million

## Summary
- Xtant Medical acquired certain assets of Surgalign Holdings, Inc. for $5 million cash plus assumed liabilities under Bankruptcy Court supervision.
- The acquisition includes inventory, intellectual property, contracts, equipment, and equity of Surgalign's international subsidiaries.
- Xtant entered into Fourth Amendments to its credit agreements with MidCap Financial Trust and MidCap Funding IV Trust to permit the transaction.
- Xtant issued a press release announcing closing and reiterated 2023 revenue guidance of $75-77 million.
- The closing follows a Sale Order issued by the U.S. Bankruptcy Court for the Southern District of Texas on August 9, 2023.

## SEC filing metadata
- accession: 0001493152-23-027585
- form_type: 8-K
- ticker: XTNT
- cik: 0001453593
- company_name: Xtant Medical Holdings, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 2.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453593/000149315223027585/0001493152-23-027585-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453593/000149315223027585/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-027585
- JSON: https://secwatch.observer/filing/0001493152-23-027585.json
- Plain text: https://secwatch.observer/filing/0001493152-23-027585.txt

## Key facts
- M&A Transactions
  Xtant Medical Holdings, Inc. completed an acquisition involving Surgalign Holdings, Inc. for $5 million (closed 2023-08-10).
  - Action: acquisition
  - Counterparty: Surgalign Holdings, Inc.
  - Consideration: $5 million
  - Closing: 2023-08-10
  source text: Seller’s bankruptcy proceedings. The Bankruptcy Court issued a Sale Order on August 9, 2023 approving and authorizing the Transaction. The Company funded the purchase price of $5 million, plus Liabilities, with cash on hand. The foregoing summary of the Asset Purchase Agreement is not complete and is qualified in its entirety by reference to the full text of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315223027585/0001493152-23-027585-index.htm
- Material Agreements
  Xtant Medical Holdings, Inc. amended Limited Consent and Amendment No. 4 to Credit, Security and Guarantee Agreement (Term Loan) with MidCap Financial Trust (effective 2023-08-10).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: MidCap Financial Trust
  - Effective: 2023-08-10
  source text: On August 10, 2023, Xtant Medical Holdings, Inc., a Delaware corporation (the “Company”), entered into a Limited Consent and Amendment No. 4 to Credit, Security and Guarantee Agreement (Term Loan) (“Term Amendment No. 4"), which amends the Credit, Security and Guarantee Agreement (Term Loan) by and among the Company, as guarantor, and its U.S. subsidiaries, as borrowers, MidCap Financial Trust, as agent, and the financial institutions party thereto (as amended, the “Term Credit Agreement”), and a Limited Consent and Amendment No. 4 to Credit, Security and Guarantee Agreement (Revolving Loan) (“Revolving Amendment No. 4"
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315223027585/0001493152-23-027585-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.